ES2121058T3 - Compuestos antibioticos de carbapenem. - Google Patents

Compuestos antibioticos de carbapenem.

Info

Publication number
ES2121058T3
ES2121058T3 ES93305608T ES93305608T ES2121058T3 ES 2121058 T3 ES2121058 T3 ES 2121058T3 ES 93305608 T ES93305608 T ES 93305608T ES 93305608 T ES93305608 T ES 93305608T ES 2121058 T3 ES2121058 T3 ES 2121058T3
Authority
ES
Spain
Prior art keywords
4alkyl
hydrogen
preparation
carbon atom
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93305608T
Other languages
English (en)
Inventor
Frederic Henri Jung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Syngenta Ltd
Original Assignee
Zeneca Pharma SA
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Pharma SA, Zeneca Ltd filed Critical Zeneca Pharma SA
Application granted granted Critical
Publication of ES2121058T3 publication Critical patent/ES2121058T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

EL PRESENTE INVENTO SE REFIERE A CARBAPENES Y PROPORCIONA UN COMPUESTO DE LA FORMULA (I) EN DONDE: R1 ES HIDROXIETIL 4; R3 ES HIDROGENO O ALQUIL C1 LAZADO AL NITROGENO DEL GRUPO CARBAMOILO DE ENLACE POR UNA ATOMO DE CARBONO, ESTA SUBSTITUIDO POR EL GRUPO CARBOXI EN UN ATOMO DE CARBONO, Y ADEMAS ESTA OPCIONALMENTE SUBSTITUIDO, EN LOS ATOMOS DE CARBONO DEL ANILLO, POR UNO O DOS SUBSTITUYENTES; UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO O UN ESTER HIDROLIZABLE "IN VIVO" DEL MISMO. TAMBIEN SE DESCRIBEN EL PROCESO PARA SU PREPARACION, INTERMEDIARIOS EN SU PREPARACION, SU EMPLEO COMO AGENTES TERAPEUTICOS Y COMPOSICIONES FARMACEUTICAS QUE LO CONTIENEN.
ES93305608T 1992-07-21 1993-07-16 Compuestos antibioticos de carbapenem. Expired - Lifetime ES2121058T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92402104 1992-07-21

Publications (1)

Publication Number Publication Date
ES2121058T3 true ES2121058T3 (es) 1998-11-16

Family

ID=8211690

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93305608T Expired - Lifetime ES2121058T3 (es) 1992-07-21 1993-07-16 Compuestos antibioticos de carbapenem.

Country Status (7)

Country Link
US (1) US5444057A (es)
JP (1) JPH06179675A (es)
KR (1) KR100278030B1 (es)
AT (1) ATE170860T1 (es)
CA (1) CA2099811A1 (es)
DE (1) DE69320896T2 (es)
ES (1) ES2121058T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2099817A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CN101613352B (zh) * 2008-06-25 2013-03-27 山东轩竹医药科技有限公司 含有甲酰胺杂环基巯基吡咯烷的培南衍生物
KR20160114385A (ko) 2015-03-24 2016-10-05 이경욱 소음 방지 구조
RU2737325C2 (ru) * 2016-03-13 2020-11-27 Иньекто Груп А/С Инъектор с уменьшенной силой сдвига

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4206219A (en) * 1978-10-24 1980-06-03 Merck & Co., Inc. 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid
US4218462A (en) * 1978-10-24 1980-08-19 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
JPS55132593A (en) * 1979-04-02 1980-10-15 Fujitsu Ltd Refresh control method for memory unit
JPS55144190U (es) * 1979-04-05 1980-10-16
DK165280A (da) * 1979-04-19 1980-10-20 Merck & Co Inc Fremgangsmaade til fremstilling af 2- og 6-substituerede 1-carbadethiapen-2-em-3-carboxylsyrer og mellemprodukter til brug ved udoevelse af fremgangsmaaden
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
EP0182213B1 (en) * 1984-11-08 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Carbapenem compounds and production thereof
ES2051700T3 (es) * 1986-03-27 1994-07-01 Sumitomo Pharma Un proceso para la preparacion de un compuesto beta-lactama.
US4925838A (en) * 1988-03-18 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
CA2036163C (en) * 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
NZ237191A (en) * 1990-02-23 1992-12-23 Sankyo Co 2-((substituted amide) substituted heterocyclylthio) carbpen-2-em derivatives and pharmaceutical compositions
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds

Also Published As

Publication number Publication date
DE69320896D1 (de) 1998-10-15
DE69320896T2 (de) 1999-01-28
KR940002245A (ko) 1994-02-17
CA2099811A1 (en) 1994-01-22
ATE170860T1 (de) 1998-09-15
KR100278030B1 (ko) 2001-02-01
JPH06179675A (ja) 1994-06-28
US5444057A (en) 1995-08-22

Similar Documents

Publication Publication Date Title
MY111685A (en) Antibiotic compounds.
IE802612L (en) Bicyclo £2.2.1| heptane derivatives
ES2121585T3 (es) Compuestos antibioticos de carbapenem.
GB9107341D0 (en) Antibiotic compounds
CA2108356A1 (en) Antibiotic compounds
MY111702A (en) 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
ES2133358T3 (es) Compuestos de carbapenem como antibioticos.
CA2155493A1 (en) Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
IE790630L (en) 2, 6-dialkoxybenzamido-pyrrolidines.
ES2121058T3 (es) Compuestos antibioticos de carbapenem.
ES2123031T3 (es) Compuestos antibioticos de carbapenem.
DE3166235D1 (en) Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
ES2140445T3 (es) Derivados de pirrolidinil-tio-penem con propiedades antibioticas.
ES8403488A1 (es) Un procedimiento para la preparacion de antibioticos b-lactamicos.
AU2002211006A1 (en) Novel beta-lactam compounds and proecss for producing the same
ES2144446T3 (es) Compuestos de carbapenem antibioticos.
IE820238L (en) Carbapenem derivatives
JO1777B1 (en) Compounds used as antibiotics
CA2129813A1 (en) 5-aminoflavone derivatives
EP0059554A3 (en) Beta-lactam antibiotics, a process for their preparation and their use in pharmaceutical compositions
YU59093A (sh) Antibiotička jedinjenja
JO1672B1 (en) Dialoxy-pyridinyl-benzimidazole derivatives and a way to prepare and use it in a pharmacy

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 581501

Country of ref document: ES